Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...
Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg.
Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New ...
The approval allows Lupin to enter the market for LEMS, rare autoimmune neuromuscular disorder affecting communication between nerve & muscle ...